4B3507).
Introduction
There are recognized variations in the morphology and macromolecular content of cartilage from different sites and at different stages of development. During limb cartilage development there is production of molecules such as tenascin (1) and fibronectin, whose levels subsequently decrease as cartilage matures and expression of cartilage-specific proteins increases (2,3). In growth plate cartilage, production of extracellular matrix components, such as Types I1 and X collagen, is altered as chondrocytes pass sequentially through proliferative, hypertrophic, and degenerative stages (4) (5) (6) . These differences in part reflect heterogeneity of chondrocyte activity (7, 8) , the control of which is unclear.
Interactions between cells and their immediately surrounding extracellular matrix via specialized cell surface receptors are important in the control of differentiation and regulation of func- tion (9) . Effects on chondrocyte differentiation in vitro by matrix proteins such as fibronectin (10) are probably mediated by these molecules. Similar control mechanisms as a result of specific temporal and spatial changes in the content of the extracellular matrix or in expression of cell adhesion molecules (11, 12) are likely to be involved in the regulation of cartilage differentiation and chondrocyte function in vivo.
Adult human articular chondrocytes express members of the integrin family of cell adhesion molecules (11) . Little is known of expression of these molecules in human fetal h p h e cartilages where controlled differentiation is important in endochondral ossification and joint formation. To assess whether or not subpopulations of chondrocytes differ in expression of cell adhesion molecules, we have undertaken an immunohistological study of human fetal knee joints using a panel of monoclonal antibodies (MAbs) against integrin molecules. The results show that fetal chondrocytes express a different integrin profile from that seen in previous studies of adult articular chondrocytes, in particular with expression of the ab-subunit. Furthermore, fetal chondrocytes in anatomically distinct cartilages around the knee vary in their expression of integrin molecules, supporting the idea that altered cell-matrix interactions mediated by these molecules may be involved in chondrocyte function and differentiation.
Materials and Methods
Tissues. Knee joints that showed no skeletal abnormality were obtained at autopsy of fetal stillbirths and mid-trimester abortions. Intact knee joints with adjacent distal femoral and proximal tibial epiphyseal and growth plate cartilage (13 second trimester abortions) 6r dissected femoral and tibial condyles (three third trimester stillbirths) were frozen in liquid nitrogen.
Immunohistology. Sections (4 pm) were cut of intact or dissected knee joints with a Brights cryostat, taken onto poly-L-lysine-coated slides, and kept at -20°C until used. Sections were allowed to come to room temperature before fixation with acetone (anal& grade; BDH Biochemical, Liverpool, UK) for 10 min. After preliminary studies to optimize staining procedures and remm matrix-associated proteoglycans, which may mask antigenic determinants, sections were pre-treated for 30 min at 37'C with 5 mglml bovine testicular hyaluronidase (13) before immunostaining with a panel of fully characterized MAbs against integrin subunits and extracellular matrix molecules (Pble l), using an ABC alkaline phosphatase technique (14) with Vector red (Vector Laboratories; Peterborough, UK) as a visualization agent. Levamizole 0.5 M was used to block endogenous alkaline phosphatase activity. Sections were examined with a Zeiss axiophot photomicroscope. External positive controls included human tonsil, but in all cases internal positive controls (fibroblasts, endothelial cells, osteoblasts, and osteoclasts) were present in sections. Negative controls were obtained by omitting the primary antibody. Table 1 
. Antibodies used in this study

Results
In the tissues studied, the knee joint was well developed and normal landmarks, including the menisci and cruciate ligaments, were identifiable. Epiphyseal cartilage could be separated into periarticular (destined to become articular cartilage), reserve zone cartilage, and epiphyseal growth cartilage ( Figure 1 ). Immunostaining of cells in each of these areas was assessed separately.
Integrin Expression
The results are shown in Table 2 and are illustrated in Meniscus. The menisci were absent from the dissected tibial condyles of the third trimester stillbirths and so results are given for second trimester fetuses only. (31, P5aV, al, a2, a5, ab, and aV were expressed by the majority of meniscal cells (Figures 2A-2F ). Compared with chondrocytes in the adjacent articular and epiphyseal cartilages, a2 immunoreactivity was much stronger in the meniscus (Figure 2D ). There was no immunoreactivity for (33, w, Articular Chondrocgtes. Articular chondrocytes in all cases showed strong expression of PI, B5aV dimer. and a 5 (Figures 2A.  2B . and 2E). a6 was also cxprcncd by the majority of articular chondrocytes in all cases. but immunoreactivity was consistently much weaker than in cells in the epiphysis and growth plate ( Figure 2F ). a1 was strongly expressed by the large majority of chondrocytes in the early gestation samples ( Figure ZC ). a2 was also present in the articular cartilage of most of the second trimester samples ( Figure  2D ), but expression was inwiably less than that of al. Immunorcactivity for both of these integrin subunits appeared to be less in the three knees from third trimester fetuses compared with second trimester samples. There was no immunostaining of articular chondrocytes for 03, pb, w. or a3. and a3. a 5 was also cxprcsscd by the majority of epiphyseal reserve cells in all cases (Figures 2 and 3 ). with chondrocytes adjacent to vascular bundles showing stronger immunoreactivity. a1 and a 2 were expressed by the majority of chondrocytes in the second trimester samples ( Figures 3A and 3C ). In the third trimester. many fewer epiphyseal cells showcd immunoreactivity and, as with a5positive cells. were more commonly seen beside vascular bundles and adjacent to the perichondrium (Figures 3B and 3D) .
Growth Phte. Proliferative and hypertrophic chondrocytes of the growth cartilage showed a consistent phenotype in all cases.
These cells expressed 81. f35aV. a5, ab. and a V inregrins (Figure   4 ). There was no immunoreactivity for P3, pb. w, al. a2, or a3.
Epiphyseal Chondrocgtes
Extracellular Matrix
Reserve Gels. Chondrocyta in the epiphysesof all cascsnrongly expressed B1, f35aV. a6, and aV but were negative for 03, pb, pb.
The results are summarized in Table 3 and illustrated in Figures 5 and 6. lmmunostaining showed variation in the intensity and distribution of a variety of integrin ligands in the extracellular matrix molecules of fetal cartilages studied. Fibronectin, as identified by IST4, an antibody that recognizes all isoforms of that molecule, was associated with chondrocytes and in the interterritorial cartilage matrix of all zones ( Figures 5A and 6A) . The ED-A and ED-B isoforms, however, were much more restricted in distribution, being strongly expressed in the articular cartilage zone and meniscus but less in epiphyseal reserve and not at all in growth cartilage ( Figures 5B and 6B) . Tenascin was similarly strongly expressed by meniscal cells and articular cartilage but not by epiphyseal reserve or growth plate chondrocytes ( Figures 5C and 6C) . Collagen VI and vitronectin were present in pericellular matrix and the interterritorial matrix in all parts of knee joint cartilage, whereas laminin, also present in all cartilages, was predominantly cell associated ( Figures 5D-5F and 6D-6F ).
Discussion
Integrins are a family of heterodimeric transmembrane glycoproteins consisting of an alpha (a)-chain which conveys ligand specificity and a beta @)-chain which provides linkage to the cytoskeleton via talin, vinculin, or a-actinin. The aand P-chains have similar tertiary structures and are non-covalently linked via their extracellular globular domains. They have a wide tissue distribution and are chiefly involved in the adhesion of cells to their underlying substratum or tissue matrix, although participation in cell-cell adhesion is becoming increasingly recognized (9J5). The (31 subfamily is the largest and contains at least eight a-chains, which have been shown to associate with (31 to form receptors for a number of adhesion glycoproteins including collagens (alpl, a2(31. a3p1), fibronectin (a3p1, a5B1, aV(31), and laminin (alpl, a2(3l, a3B1, a6(31). The study reported here shows variation of integrin expression by chondrocytes in different parts of fetal knee joints, which in part was related to the content of the extracellular matrix. Expression of integrins in fetal cartilages differs from that of chondrocytes in adult human articular cartilage that express PI, a5 and a V strongly, a1 and a3 weakly, and do not express a2 or a6 (11) . The recognized heterogeneity of chondrocytes reflected in differences of metabolism and cell shape (8, 16) therefore also extends to expression of cell adhesion molecules, enabling chondrocytes to regulate their interactions with the pericellular environment at different stages of development and differentiation.
The results presented here are broadly in agreement with those of other workers (17) who showed, by FACS analysis, expression of PI, a5, and aV by the majority of the fetal epiphyseal chondrocytes, a6 by about 40% of cells, and smaller numbers expressing at and a2. In addition, this group also reported variation in the in vitro effects of specific anti-al and anti-a2 antibodies on adhesion to collagens by chondrocytes from neonates and fetuses ofdifferent gestational age, observations in accordance with our finding of in vivo heterogeneity of expression of these molecules. The relatively higher percentage of chondrocytes identified as expressing a1 and a6 integrins in our study probably reflects the difference in techniques used. We have found that the ABC Vector red immunohistochemical technique, with its additional amplification step, is much more sensitive than standard indirect immunofluorescence. Furthermore, Durr et al. (17) did not spec+ the anatomic source of their epiphyseal cartilage. It is possible that chondrocytes in different epiphyseal cartilages, e.g., ribs and long bones, express different integrin profiles. Additional evidence of variation of integrin and other cell adhesion molecules expression by chondrocytes from different sites and age is accumulating. Pt, a3, a>, and possibly a2 are expressed by chondrocytes from the sterna of 14-day chick embryos (18) . NG2, a membrane glycoprotein that functions as a collagen VI receptor (19) , is present in developing rat limb cartilage but is downregulated at later stages of cartilage differentiation (20) .
The pattern of integrin expression identified in this and other studies (11, 17) suggests that both adult and fetal human chondrocytes preferentially express a receptor for fibronectin (a5 pi), with fetal chondrocytes also showing expression of laminin (a6pl) and vitronectin (aVp5) receptors, molecules that are appropriately present in the pericellular matrix of human fetal chondrocytes. On the other hand, there was surprising h-ei t y di"ua0rCrtivity for a1 and a2, the major collagen receptor subunits (21,22), despite the high collagen content of ad^. Chondmcytcs arc -rated from the bulk of hyaline cartilage matrix by a spccializcd pericellular environment in which a number ofzdhesion gfpcoproteins are preferentially expressed (23) . M o k~~l a such as fib-tin m y act as a bridge between the choadtmytc and collagen in territorial matrix (24, 251 , decrcving the requirement for specific integrk collagen receptors. Mtematiwly, other non-integrin *sion molecules, such as NG2. recently identified as a Typc VI collagen meptor (19) . and CD44, may be iavDLecd in choadrocgtc binding to collagen in vivo (26-28). The predominant loahation of a1 and a2 to articular cartilage niscs the possibility dwt dacse molecules are involved in c h o m h q e interactions with tenaxin (29) . which is also pr&rcnti?ny apFastd in articular cudage. The suong expression of a2 by ra~niscal cells is pwbably a reflection of their more fibroblastic than choudroqtic phenotype, the meniscus being a fibrocandlagiaous structure with Trpc I cdbgca rather than Type I1 collagen as the predominant c o m p~s n t dthc matrix (30.31).
An immunohistochemical study such as thpt llcported here provides accurate assessment din vivo loalintion ofintcgrin subunits. It must be recognized, h m , that cxprssion o f subunits does not necessarily mean that functional dimers arc prescnt. Evidence exists that integrins on a number of cells must be zctivatad to function as adhesive recepton (32.33). Examples & ofumtiaucd expression of inactive forms of some inegrk, such as a5pl and a@1, after differentiation of keratinocytes and miaal neurons (34.35). In this respect, we and others have shown p r adherence in vitro of freshly extracted adult articular chw-to a variety af adhcsion proteins, includmg fibmnectin and coUagens, despite expressionofappropriate receptors (36; and Salter et al., unpublished observations). However, adherence to these s u d is i d d~e d after a period in monolayer culture, suggesting that mature chondrocytes may express low-&inity receptors that are activared in culture conditions. Similarly, high-lffinity receptors may be expressed by chondrocytes in vivo only when the appropriate stimuli are present.
It is becoming clear that the extracellular matrix regulates development and cell differentiation (37). Controlled expression of cell adhesion molecules such as integrins, in association with variation of production of matrix proteins and their isofoms, will have important roles in chondrocyte function and cartilage development.
The distribution of a2 immunoreactivity in our study is similar to the distribution of Types I and I11 collagen in human fetal femoral heads (38), raising the possibility that expression of adhesive molecules is dependent in part on the environment in which a chondrocyte finds itself. Chondrocyte differentiation in vitro is known to be effected by exposure to extracellular matrix molecules, either individually, e.g., fibronectin (39), or when incorporated into a pericellular coat, as seen in agarose culture (40) . Both tenascin and fibronectin are variably expressed in developing limb cartilage (I,&) .
In later stages of limb and joint development, it appears that molecules such as fibronectin isoforms and tenascin may show differential expression in articular cadage and transient cartilages that will undergo maturation and be replaced by bone (42). Modification of matrix content of such molecules produced by chondrocytes themselves or by diffusion from the joint space or blood vessels will provide specific environmental information to chondrocytes. Acting in an autocrine or paracrine fashion, these matrix molecules will bind to appropriately expressed integrin receptors and, by generation of second messengers or by interactions with the actin cytoskeleton, will influence cell behavior (43).
In conclusion, chondrocytes from different sources and at different stages of development both in vivo and in vitro show heterogeneity in their expression of integrin and other cell adhesion molecules. Further work is needed to increase our understanding of the regulated expression and activity of these molecules in association with changes in the presence of specific ligands in the adjacent ex-tpceUularmatrix (44.45) that are likely to be important in the control of chondrocyte metabolism both in development and in disease processes such as osteoarthritis.
